Skip to main content
All lobbying filings

VAN SCOYOC ASSOCIATES

Lobbying for ARUP LABORATORIES, INC. · Diagnostic testing laboratory

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
Utah

Official filing document

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

Monitor the following: Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Diagnostic Lab Testing related issues President's Budget FY2027 H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, Diagnostic Lab Testing related issues

FDA regulation, Laboratory Testing related issues H.R.8890, Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Possible Health policy package Monitor the following: Health workforce visa related issues H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues Possible Reconciliation, FY2027, Health related provisions Prescription drug costs, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives

FDA regulation, Laboratory Testing related issues H.R.8890, Clinical Laboratory Improvement Amendments (CLIA), Modernization generally H.R.5269/S.2761, Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (RESULTS Act), Entirety Possible Health policy package Monitor the following: Health workforce visa related issues H.R.3152/S.1546, Patent Eligibility Restoration Act of 2025, Laboratory technology related issues Possible Reconciliation, FY2027, Health related provisions Prescription drug costs, generally Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues Public Health reporting initiatives

 Bills named in this filing 6
  • H.R. 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
  • H.R. 8890
    Enhancing CLIA Act of 2026
  • H.R. 5269
    ERAP Improvement Act of 2021
  • S. 2761
    RESULTS Act
  • H.R. 3152
    Patent Eligibility Restoration Act of 2025
  • S. 1546
    Patent Eligibility Restoration Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem